Montreal Classification (IBD Phenotype)
Montreal Classification (IBD Phenotype) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the Montreal Classification (IBD Phenotype) → Runs in your browser. No signup, no tracking.
What this is
Montreal Classification (IBD Phenotype) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Montreal Classification (IBD Phenotype) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of IBD: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5A-36A. Read the source ↗
Worked example: Montreal Crohn’s phenotype A2 L3 B2: A2 (17-40 years), L3 (ileocolonic), B2 (stricturing).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.